Viewed the Thesis/Dissertation in Its Final Electronic Format and Certify That It Is an Accurate Copy of the Document Reviewed and Approved by the Committee

Total Page:16

File Type:pdf, Size:1020Kb

Viewed the Thesis/Dissertation in Its Final Electronic Format and Certify That It Is an Accurate Copy of the Document Reviewed and Approved by the Committee U UNIVERSITY OF CINCINNATI Date: I, , hereby submit this original work as part of the requirements for the degree of: in It is entitled: Student Signature: This work and its defense approved by: Committee Chair: Approval of the electronic document: I have reviewed the Thesis/Dissertation in its final electronic format and certify that it is an accurate copy of the document reviewed and approved by the committee. Committee Chair signature: Investigation of Phosphorylated Proteins and Peptides in Human Cerebrospinal Fluid via High-Performance Liquid Chromatography Coupled to Elemental and Molecular Mass Spectrometry A thesis submitted to the Graduate School of the University of Cincinnati In partial fulfillment of the Requirements for the degree of MASTER OF SCIENCE In the Department of Chemistry of the College of Arts and Sciences By ORVILLE DEAN STUART B.S., Chemistry The University of Texas at Tyler, Tyler, Texas May 2006 Committee Chair: Joseph A. Caruso, Ph.D Abstract Cerebrospinal fluid (CSF) surrounds and serves as a protective media for the brain and central nervous system (CNS). This fluid remains isolated from other biological matrices in normal bodily conditions, therefore, an in depth analysis of CSF has the potential to reveal important details and malfunctions of many diseases that plague the nervous system. Because phosphorylation of a wide variety of proteins governs the activity of biological enzymes and systems, a method for the detection of 31P in proteins found in human cerebrospinal fluid by high-performance liquid chromatography (HPLC) coupled to inductively coupled plasma mass spectrometry (ICPMS) is described. Specifically, it is of interest to compare phosphorylated proteins/peptides from patients suffering from post subarachnoid hemorrhage (SAH) arterial vasospasms against CSF from non-diseased patients. HPLC provides a way to separate many of the components of the CSF matrix, while ICPMS allows for the simultaneous detection of various elements, specifically phosphorus, at high sensitivity. Because structural elucidation is lost in the ICPMS experiment, softer ionization techniques such as Electrospray Ionization (ESI) are thus utilized for potential protein/peptide identification. Database searching software (Spectrum Mill) is then used in this study as a means of identification and validation. SEC- ICPMS confirms the presence of phosphorylated peptides within normal CSF as well as vasospastic and non-vasospastic SAH CSF samples. Non-enzymatically digested samples with ESI-MS analysis, in conjunction with Spectrum Mill database searching, indicates a variance among phosphorylated protein species across the sample batches, however, no correlations are drawn between disease types and phosphoprotein presence or absence. iii © Copyright MMIX Orville Dean Stuart All Rights Reserved iv Preface and Acknowledgements To this day, I am often reminded of an artfully written piece of prose by Sully-Prudhomme† which, in my opinion, glamorized the daily life of a Chemist: “Surrounded by beakers, by strange coils, By ovens and flasks with twisted necks, The chemist, fathoming the whims of attractions, Artfully imposes on them their precise meetings. He controls their loves, hidden until now, Discovers and directs their secret affinities, Unites them and brings about their abrupt divorces, And purposefully guides their blind destinies.” For me, just knowing that in the grand scheme of things, I could one day be able to “guide the destiny” of some unseen object made me shiver with excitement. I suppose that’s why I decided to become a Chemist at a young age. Such a decision, I’ve realized over the years, doesn’t simply come just as a whim. Without a doubt, as a Christian, I am in constant awe of God’s wondrous “quantum” world; literally the world of the unseen. As a Scientist, I am humbled by the fact that God has seen fit to open one of the million windows to his wonders, and has allowed me to make a report about it. Of course, I must also thank my father, Dr. John G. Stuart for his ever watchful, ever thoughtful guidance throughout my chemistry career, as well as my mother, Joyce Stuart, and my siblings Holly and Jonathan for always being supportive of my, to borrow the phrase, “weird science-y stuff.” Unlike my Organic father, I decided to go down the Analytical route; so much for “guiding blind destinies.” Or so I thought, before I ventured into the world of ICPMS. Artfully breaking down molecules and compounds and ionizing them in a PLASMA of all things… “too v cool!” I would think every day as I sat in front of the instrument. Being a Sci-Fi buff, something of this nature truly seemed to have the same scientific “cool factor” as Star Trek, or Mobile Suit Gundam. It therefore goes without saying, that Dr. Joseph Caruso made this all possible. Through him, I was able to explore a childhood dream of not only “guiding the destiny” of unseen analytes, but he also allowed me to see first hand the rigors of Ph.D life through a different lens than that of my father. Throughout my graduate school and ICPMS career, the one person who constantly challenged me, both academically and personally, was Jennifer Siverling. Ever the amazing classmate, labmate, and more importantly, love of my life, Jenn without a doubt changed my life forever for the better. Every moment was a rip-roaring ride of fun, love, excitement, and lots of late nights in the Lab, slaving over instrumentation malfunctions and bad data! Even through the good and the bad, we stuck together strong… And before you ask, YES I find it something of a personal triumph that I managed to get you to like anime… well… some anime! You were right when you said it was all like an up and down rollercoaster… but you know what? That’s what made it special; it’s what made us “us,” and I would never trade a moment for the world! Well… with all that said, I suppose it’s time to get this thesis started! To old friends lost, and to new ones not fully realized…; in the same cryptic vein as Yoshiyuki Tomino‡, this one’s for you… vi “And now… In anticipation of your Insight into the future…” vii Table of Contents Abstract…………………………………………………………………………………………………………………………………… iii Preface and Acknowledgements..……………………………………………………………………………..……………… v List of Tables……………………………………………………………………………………………………………………….…… ix List of Figures………………………………………………………………………………………………………………………….… x Introduction…………………………………………………………………………………………………………………………….. 1 Cerebrospinal Fluid………………………………………………………………………………………………………. 2 Instrumental Overview…………………………………………………………………………………………………………….. 3 Inductively Coupled Plasma Mass Spectrometry………………………………………………………….. 3 Size Exclusion Chromatography…………………………………………………………………………….……… 5 Electrospray Mass Spectrometry……………………………………………………………………………..…… 6 Experimental……………………………………………………………………………………………………………………….…… 8 Results………………………………………………………………………………………………………………………………..….. 11 Chromatographic and Spectroscopic Data Analysis……………………………………………….….… 11 Protein Identification Discussion……………………………………………………………………………...… 23 Closing Remarks/Future Studies………………………………………………………………………………………..…… 28 References……………………………………………………………………………………………………………………….….… 30 Appendix 1……………………………………………………………………………………………………………………….……. 32 viii List of Tables Table Page 1. CSF sample nomenclature, disease type, and mass-volume conversion factor……………………… 9 2. Instrumental parameters………………………………………………………………………………………………….… 10 ix List of Figures Figure Page 1. Step by step diagram of microfluidic re-routing within the nanoLC Electrospray Chip………..… 7 2. 31P counts per second of “normal” control non-SAH CSF 109-Con sample………….……….……… 11 3. 31P counts per second of non-vasospastic SAH CSF samples…………………….…………………….…… 11 4. 31P counts per second of vasospastic SAH CSF samples…………………………………….………………… 12 5. Overlayed ESI BPCs of “normal” control non-SAH CSF (109-Con) and SEC-HPLC trace..………. 14 6. Overlayed ESI BPCs of non-vasospastic SAH CSF (NV 71-01) and SEC-HPLC trace……….………. 15 7. Overlayed ESI BPCs of non-vasospastic SAH CSF (NV 111-1) and SEC-HPLC trace…….…………. 16 8. Overlayed ESI BPCs of non-vasospastic SAH CSF (NV 113-1) and SEC-HPLC trace….……………. 17 9. Overlayed ESI BPCs of vasospastic SAH CSF (V 108-2) and SEC-HPLC trace…….…………………… 18 10. Overlayed ESI BPCs of vasospastic SAH CSF (V 109-2) and SEC-HPLC trace…….…………………. 19 11. Overlayed ESI BPCs of vasospastic SAH CSF (V 112-1) and SEC-HPLC trace…….…………………. 20 x Introduction The phosphorylation and dephosphorylation of both structural and regulatory proteins as post translational modifications (PTMs) are a major intracellular control mechanism present in eukaryotes [1]. With the addition of phosphate to a specific activation site, an otherwise inactive protein, or enzyme as a collective whole, may change shape due to electrostatic repulsions and interactions, adopting a new “active” conformation, wherein the protein or enzyme is prepared to perform specific biological functions [2]. When biological systems are disrupted due to outside physical trauma or internal diseases, the various ways of how regulatory proteins are spurred into action, or the resulting loss of action due to variations in phosphorylated proteins and or peptides, becomes an interesting topic to investigate and may push the discovery of biomarkers to indicate and ultimately suggest preventive measures. The controls and regulations involved within the central nervous system (CNS) are of particular interest because it is the control center of the human body. Indeed, much work has
Recommended publications
  • The Porcine Major Histocompatibility Complex and Related Paralogous Regions: a Review Patrick Chardon, Christine Renard, Claire Gaillard, Marcel Vaiman
    The porcine Major Histocompatibility Complex and related paralogous regions: a review Patrick Chardon, Christine Renard, Claire Gaillard, Marcel Vaiman To cite this version: Patrick Chardon, Christine Renard, Claire Gaillard, Marcel Vaiman. The porcine Major Histocom- patibility Complex and related paralogous regions: a review. Genetics Selection Evolution, BioMed Central, 2000, 32 (2), pp.109-128. 10.1051/gse:2000101. hal-00894302 HAL Id: hal-00894302 https://hal.archives-ouvertes.fr/hal-00894302 Submitted on 1 Jan 2000 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Genet. Sel. Evol. 32 (2000) 109–128 109 c INRA, EDP Sciences Review The porcine Major Histocompatibility Complex and related paralogous regions: a review Patrick CHARDON, Christine RENARD, Claire ROGEL GAILLARD, Marcel VAIMAN Laboratoire de radiobiologie et d’etude du genome, Departement de genetique animale, Institut national de la recherche agronomique, Commissariat al’energie atomique, 78352, Jouy-en-Josas Cedex, France (Received 18 November 1999; accepted 17 January 2000) Abstract – The physical alignment of the entire region of the pig major histocompat- ibility complex (MHC) has been almost completed. In swine, the MHC is called the SLA (swine leukocyte antigen) and most of its class I region has been sequenced.
    [Show full text]
  • Genome-Wide Gene and Pathway Analysis
    European Journal of Human Genetics (2010) 18, 1045–1053 & 2010 Macmillan Publishers Limited All rights reserved 1018-4813/10 www.nature.com/ejhg ARTICLE Genome-wide gene and pathway analysis Li Luo1, Gang Peng1, Yun Zhu2, Hua Dong1,2, Christopher I Amos3 and Momiao Xiong*,1 Current GWAS have primarily focused on testing association of single SNPs. To only test for association of single SNPs has limited utility and is insufficient to dissect the complex genetic structure of many common diseases. To meet conceptual and technical challenges raised by GWAS, we suggest gene and pathway-based GWAS as complementary to the current single SNP-based GWAS. This publication develops three statistics for testing association of genes and pathways with disease: linear combination test, quadratic test and decorrelation test, which take correlations among SNPs within a gene or genes within a pathway into account. The null distribution of the suggested statistics is examined and the statistics are applied to GWAS of rheumatoid arthritis in the Wellcome Trust Case–Control Consortium and the North American Rheumatoid Arthritis Consortium studies. The preliminary results show that the suggested gene and pathway-based GWAS offer several remarkable features. First, not only can they identify the genes that have large genetic effects, but also they can detect new genes in which each single SNP conferred a small amount of disease risk, and their joint actions can be implicated in the development of diseases. Second, gene and pathway-based analysis can allow the formation of the core of pathway definition of complex diseases and unravel the functional bases of an association finding.
    [Show full text]
  • Splicing Alternativo Y Quimerismo En Genes Del MHC De Clase III
    UNIVERSIDAD AUTÓNOMA DE MADRID FACULTAD DE CIENCIAS DEPARTAMENTO DE BIOLOGÍA Splicing alternativo y quimerismo en genes del MHC de clase III. Relación de esta región con la Artritis Reumatoide. Alternative splicing and chimerism in MHC class III genes. Relation of this region to Rheumatoid Arthritis. Memoria presentada por: Raquel López Díez para optar al grado de Doctor en Ciencias por la Universidad Autónoma de Madrid Trabajo dirigido por la Dra Begoña Aguado Orea y realizado en el Centro de Biología Molecular “Severo Ochoa” (UAM-CSIC). Madrid, 2014 DEPARTAMENTO DE BIOLOGÍA FACULTAD DE CIENCIAS UNIVERSIDAD AUTÓNOMA DE MADRID Memoria presentada por Dña Raquel López Díez para optar al grado de Doctor por la Universidad Autónoma de Madrid Directora: Dra. Begoña Aguado Orea Tutor: Dr. José Miguel Hermoso Núñez Departamento de Biología, Centro de Biología Molecular Severo Ochoa, U.A.M.-C.S.I.C. Madrid, 2014 Este trabajo ha sido realizado en el Departamento de Biología de la Facultad de Ciencias y en el Centro de Biología Molecular Severo Ochoa (C.B.M.S.O.), U.A.M.-C.S.I.C., gracias a la ayuda de una beca de Formación para Personal Universitario de la Universidad Autónoma de Madrid. ÍNDICE Abreviaturas empleadas ________________________________________________ vi SUMMARY ___________________________________________________________ ix Publications __________________________________________________________ xv Communications to meetings ____________________________________________ xv Submissions to the NCBI database ________________________________________ xv 1. INTRODUCCIÓN ___________________________________________________ 1 1.1. EL FENÓMENO DEL SPLICING Y EL SPLICING ALTERNATIVO ______________________ 3 1.1.1. Mecanismo de splicing _______________________________________________________ 4 1.1.1.1. Excepciones en el mecanismo de splicing _____________________________________ 8 1.1.2.
    [Show full text]
  • WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T (51) International Patent Classification: David [US/US]; 13539 N . 95th Way, Scottsdale, AZ C12Q 1/68 (2006.01) 85260 (US). (21) International Application Number: (74) Agent: AKHAVAN, Ramin; Caris Science, Inc., 6655 N . PCT/US20 12/0425 19 Macarthur Blvd., Irving, TX 75039 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 14 June 2012 (14.06.2012) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, English (25) Filing Language: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, Publication Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, (30) Priority Data: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 61/497,895 16 June 201 1 (16.06.201 1) US MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 61/499,138 20 June 201 1 (20.06.201 1) US OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, 61/501,680 27 June 201 1 (27.06.201 1) u s SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, 61/506,019 8 July 201 1(08.07.201 1) u s TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Genes Between the Complement Cluster and HLA-B THOMAS SPIES*, MAUREEN BRESNAHAN, and JACK L
    Proc. Nati. Acad. Sci. USA Vol. 86, pp. 8955-8958, November 1989 Immunology Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B THOMAS SPIES*, MAUREEN BRESNAHAN, AND JACK L. STROMINGER Department of Biochemistry and Molecular Biology, Harvard University, Cambridge, MA 02138 Contributed by Jack L. Strominger, August 15, 1989 ABSTRACT A 600-kilobase (kb) DNA segment from the meric side, the gene for 21-OHB is 350 kb distant from the human major histocompatibility complex (MHC) class HI nearest class II locus, DR. Presently, no genes have been region was isolated by extension of a previous 435-kb chromo- localized within this region. On the telomeric side, the gene some walk. The contiguous series of cloned overlapping for C2 is separated by 600 kb from the proximal class I locus, cosmids contains the entire 555-kb interval between C2 in the HLA-B. This interval includes the genes for the tumor complement gene cluster and HLA-B. This region is known to necrosis factors (TNFs) a and 83 and the major heat shock encode the tumor necrosis factors (TNFs) a and (, B144, and protein HSP70 (7, 8, 11). the major heat shock protein HSP70. Moreover, a cluster of To identify genes within the MHC class III region, a 435-kb genes, BAT1-BAT5 (HLA-B-associated transcripts) has been genomic segment centromeric to HLA-B has recently been localized in the vicinity of the genes for TNFa and TNF3. An isolated by chromosome walking with overlapping cosmids additional four genes were identified by isolation of corre- (12).
    [Show full text]
  • Xenopus in the Amphibian Ancestral Organization of the MHC Revealed
    Ancestral Organization of the MHC Revealed in the Amphibian Xenopus Yuko Ohta, Wilfried Goetz, M. Zulfiquer Hossain, Masaru Nonaka and Martin F. Flajnik This information is current as of September 26, 2021. J Immunol 2006; 176:3674-3685; ; doi: 10.4049/jimmunol.176.6.3674 http://www.jimmunol.org/content/176/6/3674 Downloaded from References This article cites 70 articles, 21 of which you can access for free at: http://www.jimmunol.org/content/176/6/3674.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 26, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Ancestral Organization of the MHC Revealed in the Amphibian Xenopus1 Yuko Ohta,2* Wilfried Goetz,* M. Zulfiquer Hossain,* Masaru Nonaka,† and Martin F. Flajnik* With the advent of the Xenopus tropicalis genome project, we analyzed scaffolds containing MHC genes. On eight scaffolds encompassing 3.65 Mbp, 122 MHC genes were found of which 110 genes were annotated.
    [Show full text]
  • Meta-Analyses Identify 13 Loci Associated with Age at Menopause
    Edinburgh Research Explorer Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways Citation for published version: Stolk, L, Zillikens, MC, Uitterlinden, AG, Visser, JA, Hofman, A, Van Duijn, CM, Perry, JRB, Melzer, D, Murray, A, Chasman, DI, Paré, G, Buring, JE, Crisponi, L, Ridker, PM, He, C, Mangino, M, Zhai, G, Burri, A, Soranzo, N, Spector, TD, Sulem, P, Gudbjartsson, DF, Stacey, SN, Styrkarsdottir, U, Stefansson, K, Thorsteinsdottir, U, Barbalic, M, Boerwinkle, E, Broer, L, Van Wingerden, S, Janssens, ACJW, Byrne, EM, Martin, NG, Medland, SE, Nyholt, DR, Montgomery, GW, Ernst, F, Esko, T, Fischer, K, Haller, T, Hass, M, Salumets, A, Metspalu, A, Völzke, H, Franceschini, N, Hottenga, J-J, De Geus, EJC, Vink, JM, Willemsen, G, Boomsma, DI, Kraft, P, Chen, C, Hankinson, SE, Hu, FB, Hunter, DJ, McArdle, PF, Yerges-Armstrong, LM, Streeten, EA, Porcu, E, Ferreli, L, Lai, S, Marongiu, M, Sanna, S, Uda, M, Shin, S-Y, Deloukas, P, Palotie, A, Stirrups, K, Smith, AV, Aspelund, T, Eiriksdottir, G, Emilsson, V, Gudnason, V, Tryggvadottir, L, Zhuang, WV, Lunetta, KL, Albrecht, E, Gieger, C, Alizadeh, BZ, Snieder, H, Stolk, RP, Bandinelli, S, Lauc, LB, Beckmann, JS, Kutalik, Z, Boban, M, Kolcic, I, Polasek, O, Rudan, I, Zemunik, T, Broekmans, FJ, Fauser, BCJM, Voorhuis, M, Campbell, H, Wilson, JF, Zgaga, L, Chanock, SJ, Cornelis, MC, Van Dam, RM, Corre, T, Masciullo, C, Pistis, G, Sala, C, Toniolo, D, Coviello, AD, Glazer, N, Murabito, JM, Johnson, AD, Karasik, D, Kiel, DP, D'Adamo, P, Gasparini,
    [Show full text]
  • INFORMATION to USERS This Manuscript Has Been Reproduced
    INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand comer and continuing from left to right in equal sections with small overlaps. Each original is also photographed in one exposure and is included in reduced form at the back of the book. Photographs included in the original manuscript have been reproduced xerographically in this copy. Higher quality 6" x 9" black and white photographic prints are available for any photographs or illustrations appearing in this copy for an additional charge. Contact UMI directly to order. A Bell & Howell InformationCompany 300 North Zeeb Road. Ann Arbor. Ml 48106-1346 USA 313.'761-4700 800/521-0600 THE H-2S/D REGION OF THE MOUSE MAJOR HISTOCOMPATIBILITY COMPLEX: COSMID CLONING, NOVEL GENE IDENTIFICATION, AND TISSUE EXPRESSION STUDIES DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of the Ohio State University By Dennis Keith Lanning, B.S.
    [Show full text]
  • Supporting Information
    Supporting Information Poulogiannis et al. 10.1073/pnas.1009941107 SI Materials and Methods Loss of Heterozygosity (LOH) Analysis of PARK2. Seven microsatellite Bioinformatic Analysis of Genome and Transcriptome Data. The markers (D6S1550, D6S253, D6S305, D6S955, D6S980, D6S1599, aCGH package in R was used to identify significant DNA copy and D6S396) were amplified for LOH analysis within the PARK2 number (DCN) changes in our collection of 100 sporadic CRCs locus using primers that were previously described (8). (1) (Gene Expression Omnibus, accession no. GSE12520). The MSP of the PARK2 Promoter. CpG sites within the PARK2 promoter aCGH analysis of cell lines and liver metastases was derived region were detected using the Methprimer software (http://www. from published data (2, 3). Chromosome 6 tiling-path array- urogene.org/methprimer/index.html). Methylation-specificand CGH was used to identify the smallest and most frequently al- control primers were designed using the Primo MSP software tered regions of DNA copy number change on chromosome 6. (http://www.changbioscience.com/primo/primom.html); bisulfite An integrative approach was used to correlate expression pro- modification of genomic DNA was performed as described pre- files with genomic copy number data from a SNP array from the viously (9). All tumor DNA samples from primary CRC tumors same tumors (n = 48) (4) (GSE16125), using Pearson’s corre- (n = 100) and CRC lines (n = 5), as well as those from the leukemia lation coefficient analysis to identify the relationships between cell lines KG-1a (acute myeloid leukemia, AML), U937 (acute DNA copy number changes and gene expression of those genes lymphoblastic leukemia, ALL), and Raji (Burkitt lymphoma, BL) SssI located within the small frequently altered regions of DCN were screened as part of this analysis.
    [Show full text]
  • Npgrj NMETH 1224 597..600
    BRIEF COMMUNICATIONS ‘isoform space’ in more complex organisms may partly explain the Isoform discovery by paradoxical lack of correlation between organismal complexity and gene number, and underscores the need to efficiently and compre- targeted cloning, ‘deep- hensively capture the full ORFeome. Historically, determination of intron-exon boundaries in eukaryotes has been addressed mainly methods well’ pooling and parallel by large-scale sequencing of random cDNAs (expressed sequence tags; ESTs) followed by alignment to a reference genomic DNA sequencing sequence. Although EST collections are extremely helpful, the human isoform space remains underexplored. A targeted cloning .com/nature e Kourosh Salehi-Ashtiani1,2,5, Xinping Yang1,2,5, and full-length sequencing strategy could provide the desired Adnan Derti1,3,5, Weidong Tian1,3,5, Tong Hao1,2,5, information but is impractically resource-intensive. .natur 1,2 4 4 Next-generation parallel sequencing technologies, such as the w Chenwei Lin , Kathryn Makowski , Lei Shen , Roche 454 FLX, offer the prospect of sequencing at a much faster Ryan R Murray1,2, David Szeto1,2, Nadeem Tusneem4, 4 1,2 1,2 pace and lower cost than conventional Sanger sequencing–based Douglas R Smith ,MichaelECusick ,DavidEHill , capillary platforms3. Most applications described so far have entailed http://ww 1,3 1,2 Frederick P Roth & Marc Vidal resequencing of megabase-scale genomic DNA fragments4–7 or of small sequence tags8–11. A disadvantage of the latter approach is that oup r Describing the ‘ORFeome’ of an organism, including all major G cis connectivity is lost between the reads; therefore, although the isoforms, is essential for a system-level understanding of reads can be assembled into contigs, mRNAs cannot be assembled any species; however, conventional cloning and sequencing unambiguously when splice variants are involved.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,784,836 B2
    US008784836B2 (12) UnitedO States Patent (10) Patent No.: US 8,784,836 B2 Szalay et al. (45) Date of Patent: *Jul. 22, 2014 (54) MICROORGANISMS FORTHERAPY 5,221,623 A 6/1993 Legocki et al. ............ 435/252.3 5,283,187 A 2f1994 Aebischer et al. ... 435/182 (75) Inventors: Aladar A. Szalay, Highland, CA (US). 5,364,7735,300,436 A 1 4,1/1994 1994 PaolettiGoldstein et etal. al. ..... .. ... 435/69.1435/190 Tatyana Timiryasova, San Diego, CA 5,368,855. A 1 1/1994 Boyle et al. ................ 435/320.1 (US); Yong A. Yu, San Diego, CA (US); 5,378.457 A 1/1995 Paoletti et al. ............. 424/205.1 Qian Zhang, San Diego, CA (US) 5,494,807 A 2f1996 Paoletti .......... ... 435/69.3 5,550,050 A 8, 1996 Holland et al. ... 435/.382 (73) Assignee: Genelux Corporation, San Diego, CA 5,639,275 A 6/1997 Baetge et al. ...... 604/891.1 (US) 5,646.298 A 7/1997 Powell et al. ...... ... 548/427 5,650,135 A 7/1997 Contaget al. .. ... 424/9.1 - 5,650,148 A 7/1997 Gage et al. ..... ... 424/93.2 (*) Notice: Subject to any disclaimer, the term of this 5,653,975 A 8/1997 Baetge et al. .. ... 424,931 patent is extended or adjusted under 35 5,656,481 A 8/1997 Baetge et al. ...... 435/325 U.S.C. 154(b) by 0 days. 5,676,943 A 10/1997 Baetge et al. .. 424.93.21 5,693,533 A 12/1997 Raney et al.
    [Show full text]
  • Variants in the GH-IGF Axis Confer Susceptibility to Lung Cancer
    Downloaded from genome.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press Letter Variants in the GH-IGF axis confer susceptibility to lung cancer Matthew F. Rudd,1 Emily L. Webb,1 Athena Matakidou,1 Gabrielle S. Sellick,1 Richard D. Williams,2 Helen Bridle,3 Tim Eisen,3,4 Richard S. Houlston,1,4,5 and the GELCAPS Consortium6 1Section of Cancer Genetics, 2Section of Paediatrics, and 3Section of Medicine, Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom We conducted a large-scale genome-wide association study in UK Caucasians to identify susceptibility alleles for lung cancer, analyzing 1529 cases and 2707 controls. To increase the likelihood of identifying disease-causing alleles, we genotyped 1476 nonsynonymous single nucleotide polymorphisms (nsSNPs) in 871 candidate cancer genes, biasing SNP selection toward those predicted to be deleterious. Statistically significant associations were identified for 64 nsSNPs, generating a genome-wide significance level of P = 0.002. Eleven of the 64 SNPs mapped to genes encoding pivotal components of the growth hormone/insulin-like growth factor (GH-IGF) pathway, including CAMKK1 E375G (OR = 1.37, P =5.4×10−5), AKAP9 M463I (OR = 1.32, P =1.0×10−4) and GHR P495T (OR = 12.98, P = 0.0019). Significant associations were also detected for SNPs within genes in the DNA damage-response pathway, including BRCA2 K3326X (OR = 1.72, P = 0.0075) and XRCC4 I137T (OR = 1.31, P = 0.0205). Our study provides evidence that inherited predisposition to lung cancer is in part mediated through low-penetrance alleles and specifically identifies variants in GH-IGF and DNA damage-response pathways with risk of lung cancer.
    [Show full text]